RecruitingNot ApplicableNCT07009327
Efficacy and Safety of Photodynamic Therapy for CIN3
Efficacy and Safety of Photodynamic Therapy for Cervical Intraepithelial Neoplasia 3(CIN3):A Multicenter Prospective Cohort Study
Sponsor
Peking University Third Hospital
Enrollment
100 participants
Start Date
Jan 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
To investigate the efficacy and safety of photodynamic therapy (20% 5-amino-ketovalerate 630nm red light) in the treatment of cervical intraepithelial neoplasia 3(CIN 3)in women in the real world
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years
Inclusion Criteria4
- CIN3, photodynamic therapy was required,
- type 1 2 transformation area, colposcopy was sufficient
- the lesion boundary was completely visible
- The ECC did not indicate high-grade lesions
Exclusion Criteria5
- coexistence or suspicion of cancer;
- TCT HSIL
- involving glands
- Porphyria patients, or suspected allergic to red and blue light.
- severe medical comorbidities；
Interventions
PROCEDUREALA-PDT
use ALA\_PDT to treat the disease
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07009327